Events & Presentations

Upcoming Events
Date Event Details Remind Me
Nov 30, 2021
Piper Sandler 33rd Annual Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Dec 2, 2021 1:00 PM EST
4th Annual Evercore ISI HealthCONx Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Dec 3, 2021
18th Global Cardiovascular Clinical Trialists Forum
James Hamilton, MD, MBA, Arrowhead’s senior vice president of discovery & translational medicine, will participate in a panel discussion titled, “Developments in Hypertriglyceridemia Trials”
Archived Events
Date Event Details
Mar 27 - Mar 30, 2019
CSHL Meeting: RNA & Oligonucleotide Therapeutics
Cold Spring Harbor, NY
Dr. Hamilton will deliver an oral presentation titled, “Cardiovascular and lipid disorders - A next frontier for TRiMTM RNAi”
Mar 26, 2019 4:35 PM EDT
Oligonucleotide & Precision Therapeutics (OPT) Congress
Cambridge, MA
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”
Mar 18, 2019 9:30 AM EDT
Jefferies HBV Investor Summit
New York
Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst
Mar 12, 2019 4:20 PM EDT
Barclays Global Healthcare Conference 2019
Miami
Bruce Given, M.D., Arrowhead’s chief operating officer, will deliver a corporate presentation.
Feb 22, 2019
APASL 2019
Dr. Edward Gane will deliver a poster presentation titled, “RNA interference (RNAi) in chronic hepatitis B (CHB): Data from Phase 2 study with JNJ-3989”
Feb 7, 2019 4:30 PM EST
Arrowhead Pharmaceuticals 2019 First Quarter Results
Dec 11, 2018 4:30 PM EST
Arrowhead 2018 Fiscal Year End Results
Nov 28, 2018
30th Annual Piper Jaffray Healthcare Conference
New York, NY
November 28, 3:30 p.m. EST – Dr. Anzalone will participate in a fireside chat
Nov 16, 2018
China Nucleic Acids
Guangzhou, China
November 16, 11:20 – Dr. Li will deliver an oral presentation titled, “TRiMTM Platform Based RNAi Therapeutics for AATD and Cardiometabolic Diseases”
Nov 15, 2018
Jefferies 2018 London Healthcare
London
November 15, 2:00 p.m. GMT – Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation